AntiThr Cancer Research Results
AntiThr, antithrombotic: Click to Expand ⟱
| Source: |
| Type: |
An antithrombotic agent is a drug that reduces the formation of blood clots.
|
Scientific Papers found: Click to Expand⟱
eff↑, AntiThr↑, Bacteria↓, LDH↓, TumCP↓, TumCCA↑, Bcl-2↓, Cyt‑c↑, Casp3↑,
*cardioP↑, Risk↓, *BMD↑, *eff↑, *antiOx↑, *lipid-P↓, *LDL↓, AntiThr↑, AntiAg↑, PSA↓, TumCCA↑, cognitive↑, memory↑,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis(tgid=4) ⓘ
LDH↓, 1,
Cell Death(tgid=5) ⓘ
Bcl-2↓, 1, Casp3↑, 1, Cyt‑c↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
AntiThr↑, 2,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 2,
Migration(tgid=13) ⓘ
AntiAg↑, 1, TumCP↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
PSA↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
LDH↓, 1, PSA↓, 1,
Functional Outcomes(tgid=23) ⓘ
cognitive↑, 1, memory↑, 1, Risk↓, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 16
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, lipid-P↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
LDL↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
BMD↑, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 1,
Total Targets: 6
Scientific Paper Hit Count for: AntiThr, antithrombotic
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1388 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page